Cargando…

Symptoms, symptom relief and support in COVID-19 patients dying in hospitals during the first pandemic wave

BACKGROUND: At the time of the first wave of the COVID-19 pandemic in Sweden, little was known about how effective our regular end-of-life care strategies would be for patients dying from COVID-19 in hospitals. The aim of the study was to describe and evaluate end-of-life care for patients dying fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Martinsson, Lisa, Bergström, Jonas, Hedman, Christel, Strang, Peter, Lundström, Staffan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247619/
https://www.ncbi.nlm.nih.gov/pubmed/34210312
http://dx.doi.org/10.1186/s12904-021-00785-4
_version_ 1783716554697867264
author Martinsson, Lisa
Bergström, Jonas
Hedman, Christel
Strang, Peter
Lundström, Staffan
author_facet Martinsson, Lisa
Bergström, Jonas
Hedman, Christel
Strang, Peter
Lundström, Staffan
author_sort Martinsson, Lisa
collection PubMed
description BACKGROUND: At the time of the first wave of the COVID-19 pandemic in Sweden, little was known about how effective our regular end-of-life care strategies would be for patients dying from COVID-19 in hospitals. The aim of the study was to describe and evaluate end-of-life care for patients dying from COVID-19 in hospitals in Sweden up until up until 12 November 2020. METHODS: Data were collected from the Swedish Register of Palliative Care. Hospital deaths during 2020 for patients with COVID-19 were included and compared to a reference cohort of hospital patients who died during 2019. Logistic regression was used to compare the groups and to control for impact of sex, age and a diagnosis of dementia. RESULTS: The COVID-19 group (1476 individuals) had a lower proportion of women and was older compared to the reference cohort (13,158 individuals), 81.8 versus 80.6 years (p < .001). Breathlessness was more commonly reported in the COVID-19 group compared to the reference cohort (72% vs 43%, p < .001). Furthermore, anxiety and delirium were more commonly and respiratory secretions, nausea and pain were less commonly reported during the last week in life in the COVID-19 group (p < .001 for all five symptoms). When present, complete relief of anxiety (p = .021), pain (p = .025) and respiratory secretions (p = .037) was more often achieved in the COVID-19 group. In the COVID-19 group, 57% had someone present at the time of death compared to 77% in the reference cohort (p < .001). CONCLUSIONS: The standard medical strategies for symptom relief and end-of-life care in hospitals seemed to be acceptable. Symptoms in COVID-19 deaths in hospitals were relieved as much as or even to a higher degree than in hospitals in 2019. Importantly, though, as a result of closing the hospitals to relatives and visitors, patients dying from COVID-19 more frequently died alone, and healthcare providers were not able to substitute for absent relatives.
format Online
Article
Text
id pubmed-8247619
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-82476192021-07-02 Symptoms, symptom relief and support in COVID-19 patients dying in hospitals during the first pandemic wave Martinsson, Lisa Bergström, Jonas Hedman, Christel Strang, Peter Lundström, Staffan BMC Palliat Care Research Article BACKGROUND: At the time of the first wave of the COVID-19 pandemic in Sweden, little was known about how effective our regular end-of-life care strategies would be for patients dying from COVID-19 in hospitals. The aim of the study was to describe and evaluate end-of-life care for patients dying from COVID-19 in hospitals in Sweden up until up until 12 November 2020. METHODS: Data were collected from the Swedish Register of Palliative Care. Hospital deaths during 2020 for patients with COVID-19 were included and compared to a reference cohort of hospital patients who died during 2019. Logistic regression was used to compare the groups and to control for impact of sex, age and a diagnosis of dementia. RESULTS: The COVID-19 group (1476 individuals) had a lower proportion of women and was older compared to the reference cohort (13,158 individuals), 81.8 versus 80.6 years (p < .001). Breathlessness was more commonly reported in the COVID-19 group compared to the reference cohort (72% vs 43%, p < .001). Furthermore, anxiety and delirium were more commonly and respiratory secretions, nausea and pain were less commonly reported during the last week in life in the COVID-19 group (p < .001 for all five symptoms). When present, complete relief of anxiety (p = .021), pain (p = .025) and respiratory secretions (p = .037) was more often achieved in the COVID-19 group. In the COVID-19 group, 57% had someone present at the time of death compared to 77% in the reference cohort (p < .001). CONCLUSIONS: The standard medical strategies for symptom relief and end-of-life care in hospitals seemed to be acceptable. Symptoms in COVID-19 deaths in hospitals were relieved as much as or even to a higher degree than in hospitals in 2019. Importantly, though, as a result of closing the hospitals to relatives and visitors, patients dying from COVID-19 more frequently died alone, and healthcare providers were not able to substitute for absent relatives. BioMed Central 2021-07-01 /pmc/articles/PMC8247619/ /pubmed/34210312 http://dx.doi.org/10.1186/s12904-021-00785-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Martinsson, Lisa
Bergström, Jonas
Hedman, Christel
Strang, Peter
Lundström, Staffan
Symptoms, symptom relief and support in COVID-19 patients dying in hospitals during the first pandemic wave
title Symptoms, symptom relief and support in COVID-19 patients dying in hospitals during the first pandemic wave
title_full Symptoms, symptom relief and support in COVID-19 patients dying in hospitals during the first pandemic wave
title_fullStr Symptoms, symptom relief and support in COVID-19 patients dying in hospitals during the first pandemic wave
title_full_unstemmed Symptoms, symptom relief and support in COVID-19 patients dying in hospitals during the first pandemic wave
title_short Symptoms, symptom relief and support in COVID-19 patients dying in hospitals during the first pandemic wave
title_sort symptoms, symptom relief and support in covid-19 patients dying in hospitals during the first pandemic wave
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247619/
https://www.ncbi.nlm.nih.gov/pubmed/34210312
http://dx.doi.org/10.1186/s12904-021-00785-4
work_keys_str_mv AT martinssonlisa symptomssymptomreliefandsupportincovid19patientsdyinginhospitalsduringthefirstpandemicwave
AT bergstromjonas symptomssymptomreliefandsupportincovid19patientsdyinginhospitalsduringthefirstpandemicwave
AT hedmanchristel symptomssymptomreliefandsupportincovid19patientsdyinginhospitalsduringthefirstpandemicwave
AT strangpeter symptomssymptomreliefandsupportincovid19patientsdyinginhospitalsduringthefirstpandemicwave
AT lundstromstaffan symptomssymptomreliefandsupportincovid19patientsdyinginhospitalsduringthefirstpandemicwave